Back to resultsUVA1 Phototherapy in Acral Vitiligo
Primary Purpose
Acral Vitiligo
Status
Completed
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
phototherapy
Sponsored by
About this trial
This is an interventional treatment trial for Acral Vitiligo
Eligibility Criteria
Inclusion Criteria:
- Patients with acral vitiligo.
- Patients more than 12 years old.
Exclusion Criteria:
- Patients less than 12 years old.
- Patients with any other skin diseases or autoimmune diseases.
- Patients taking medical treatment or phototherapy for vitiligo.
Sites / Locations
- Maha Fathy Elmasry
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
UVA1 phototherapy
Topical PUVA
Arm Description
UVA1 phototherapy in acral vitiligo
Topical PUVA in acral vitiligo
Outcomes
Primary Outcome Measures
effect of medium dose UVA1 phototherapy in treatment of acral vitiligo
effect of medium dose UVA1 phototherapy in treatment of acral vitiligo using point counting and vitiligo area severity index (VASI) score
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03378011
Brief Title
UVA1 Phototherapy in Acral Vitiligo
Official Title
The Role of Long Wavelength UVA1 Phototherapy in Acral Vitiligo
Study Type
Interventional
2. Study Status
Record Verification Date
December 2017
Overall Recruitment Status
Completed
Study Start Date
November 2015 (Actual)
Primary Completion Date
November 2016 (Actual)
Study Completion Date
November 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Cairo University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
5. Study Description
Brief Summary
evaluate the effect of UVA1 phototherapy in the treatment of acral vitiligo.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acral Vitiligo
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
20 (Actual)
8. Arms, Groups, and Interventions
Arm Title
UVA1 phototherapy
Arm Type
Active Comparator
Arm Description
UVA1 phototherapy in acral vitiligo
Arm Title
Topical PUVA
Arm Type
Active Comparator
Arm Description
Topical PUVA in acral vitiligo
Intervention Type
Other
Intervention Name(s)
phototherapy
Intervention Description
phototherapy either UVA1 or topical PUVA on acral vitiligo
Primary Outcome Measure Information:
Title
effect of medium dose UVA1 phototherapy in treatment of acral vitiligo
Description
effect of medium dose UVA1 phototherapy in treatment of acral vitiligo using point counting and vitiligo area severity index (VASI) score
Time Frame
1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with acral vitiligo.
Patients more than 12 years old.
Exclusion Criteria:
Patients less than 12 years old.
Patients with any other skin diseases or autoimmune diseases.
Patients taking medical treatment or phototherapy for vitiligo.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Maha Elmasry
Organizational Affiliation
Cairo University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Maha Fathy Elmasry
City
Cairo
Country
Egypt
12. IPD Sharing Statement
Learn more about this trial
UVA1 Phototherapy in Acral Vitiligo
We'll reach out to this number within 24 hrs